Ubs Group Ag Laboratory Corp Of America Holdings Put Options Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 08, 2023	SELL	$203.72 - $248.97 $20,372 - $24,897	-100 Reduced 50.0%	100 $23,000
Q3 2022 Nov 10, 2022	BUY	$204.81 - $262.19 $40,962 - $52,438	200 New	200 $41,000
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $27,160 - $31,420	100 Added 100.0%	200 $63,000
Q4 2020 Feb 11, 2021	SELL	$186.91 - $214.42 $1.33 Million - $1.52 Million	-7,100 Reduced 98.61%	100 $20,000
Q3 2020 Nov 12, 2020	BUY	$167.03 - $201.3 $1.19 Million - $1.43 Million	7,100 Added 7100.0%	7,200 $1.36 Million
Q2 2020 Jul 31, 2020	SELL	$113.31 - $182.44 $815,832 - $1.31 Million	-7,200 Reduced 98.63%	100 $17,000
Q1 2020 May 01, 2020	BUY	$104.32 - $195.28 $761,536 - $1.43 Million	7,300 New	7,300 $923,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.